SWEDEPAD Interim Analysis: No Mortality Difference with Paclitaxel vs. Uncoated Devices in PAD
An unplanned interim analysis of a randomized trial in which patients with peripheral artery disease received treatment with paclitaxel-coated or uncoated endovascular devices found that there was no difference in all-cause mortality.